This in-frame fusion transcript retained both MSI2 RNA recognition domains and the HOXA9 homeobox domain, raising the potential for previously uncharacterized roles in CML progression. This evidence concerns the gene HOXA9 and chronic myelogenous leukemia, BCR-ABL1 positive.